Sumant Inamdar

Dr. Sumant Inamdar


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SISumant Inamdar
Sumant Inamdar
ESEoin Slattery
Eoin Slattery
DSDivyesh V. Sejpal
Divyesh V. Sejpal
LMLarry S. Miller
Larry S. Miller
DPDouglas K. Pleskow
Douglas K. Pleskow
ATArvind J. Trindade
Arvind J. Trindade

15 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Hemant GoyalHemant Goyal
Hemant Goyal
RMRupinder Mann
Rupinder Mann
ZGZainab Gandhi
Zainab Gandhi
APAbhilash Perisetti
Abhilash Perisetti
AAAman Ali
Aman Ali
SISumant Inamdar
Sumant Inamdar
Globally, colorectal cancer is the third most diagnosed malignancy. It causes significant mortality and morbidity, which can be reduced by early diagnosis with an effective screening test. Integrating artificial intelligence (AI) and computer-aided detection (CAD) with screening methods has shown promising colorectal cancer screening results. AI could provide a “second look” for endoscopists to decrease the rate of missed polyps during a colonoscopy. It can also improve detection and characterization of polyps by integration with colonoscopy and various advanced endoscopic modalities such as magnifying narrow-band imaging, endocytoscopy, confocal endomicroscopy, laser-induced fluorescence spectroscopy, and magnifying chromoendoscopy. This descriptive review discusses various AI and CAD applications in colorectal cancer screening, polyp detection, and characterization.

12 October 2024 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SSSahib Singh
Sahib Singh
SRSyed Hamaad Rahman
Syed Hamaad Rahman
NKNihal Khan
Nihal Khan
ARAnjali Rajagopal
Anjali Rajagopal
NSNouman Shafique
Nouman Shafique
BMBabu P. Mohan
Babu P. Mohan

1 June 2011 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
YYYuchi Young
Yuchi Young
SISumant Inamdar
Sumant Inamdar
BDBeth S. Dichter
Beth S. Dichter
HKHarold Kilburn
Harold Kilburn
EHEdward L. Hannan
Edward L. Hannan

28 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DDDushyant Singh Dahiya
Dushyant Singh Dahiya
YSYash Shah
Yash Shah
HAHassam Ali
Hassam Ali
SCSaurabh Chandan
Saurabh Chandan
MGManesh Kumar Gangwani
Manesh Kumar Gangwani
SISumant Inamdar
Sumant Inamdar
Pancreatic cancer is one of the leading causes of cancer-related deaths worldwide. Pancreatic lesions consist of both neoplastic and non-neoplastic lesions and often pose a diagnostic and therapeutic challenge due to similar clinical and radiological features. In recent years, pancreatic lesions have been discovered more frequently as incidental findings due to the increased utilization and widespread availability of abdominal cross-sectional imaging. Therefore, it becomes imperative to establish an early and appropriate diagnosis with meticulous differentiation in an attempt to balance unnecessary treatment of benign pancreatic lesions and missing the opportunity for early intervention in malignant lesions. Endoscopic ultrasound (EUS) has become an important diagnostic modality for the identification and risk stratification of pancreatic lesions due to its ability to provide detailed imaging and acquisition of tissue samples for analysis with the help of fine-needle aspiration/biopsy. The recent development of EUS-based technology, including contrast-enhanced endoscopic ultrasound, real-time elastography–endoscopic ultrasound, miniature probe ultrasound, confocal laser endomicroscopy, and the application of artificial intelligence has significantly augmented the diagnostic accuracy of EUS as it enables better evaluation of the number, location, dimension, wall thickness, and contents of these lesions. This article provides a comprehensive overview of the role of the different types of EUS available for the diagnosis and differentiation of pancreatic cancer from other pancreatic lesions while discussing their key strengths and important limitations.